“The interests of the subject must always prevail over those of science and society”

World Medical Association, Declaration of Helsinki, 1961 

How many clinical trials in oncology today meet this basic moral requirement?

Asking a patient to lay down their lives in the name of scientific progress, and for the potential benefit of a future patient is a fundamentally flawed idea, that contradicts the very survival instinct that has driven millions of years of human evolution. A quick glance at oncological clinical trial enrolment rates provides the hard evidence.

This website has been built by patients and their relatives to encourage and facilitate patient orientated oncological research, bringing together every stakeholder in the cancer paradigm for the first time: patients, doctors, researchers, regulators, and funding partners.

There are many cancers where survival rates are still appalling, particularly those with orphan status where patient populations are not large enough to make private sector engagement economically viable. We felt there was an urgent requirement for a single platform where all cancer stakeholders could contribute expertise and cross-reference experimental research across different cancer silos. We want to see more clinical trial designs that offer a meaningful chance of survival to patients facing acute diagnosis – compassionate fatalism is not acceptable as a standard of care.